Find your path to Mark
3 people in our graph share verified history with Mark — schools, employers, funds. One of them is your warm intro.
Adam SeabrookunlockedMark: together at Numerion Labs
×2Mark: together at Numerion Labs
VP, Medicinal Chemistry at Numerion LabsYC W15
Intro paths
YC
Numerion Labs went through Y Combinator (Winter 2015) — Mark is an executive there, so any YC alum in your network can reach them through the company's founders.
→
In turn, Mark can intro founders to Numerion Labs's investors below.
Numerion Labs's investors · 4
.jpeg){kind=logo}
Co-founders at Numerion Labs
AL
Alex LevyFounder
IW
Izhar WallachFounder
Experience
- Numerion LabsVP Chemistry Numerion Labscurrent2023 — present
- Turning Point TherapeuticsDirector Medicinal Chemistrycurrent2022 — presentSan Diego County, California, United States
- Turning Point TherapeuticsDirector Medicinal Chemistrycurrent2022 — presentSan Diego, California, United States
- Turning Point TherapeuticsDirector Medicinal Chemistrycurrent2022 — presentSan Diego, California, United States
- TakedaAssociate Director GI Chemistry2017 — 2022San Diego, California, United States
- TakedaPrinciple Scientist Medicinal Chemistry2011 — 2017San Diego, California, United States
- TakedaSenior Scientist2006 — 2011
Frequently asked questions
- Who is Mark Sabat?
- VP, Medicinal Chemistry at Numerion Labs
- Where does Mark Sabat work?
- Mark Sabat is VP, Medicinal Chemistry at Numerion Labs.
Shared employers
Also worked at Turning Point Therapeutics4
Also worked at Takeda77
Rebecca RedfieldSenior Associate at .406 VenturesAtsushi ShimadaSenior Principal at AN Venture PartnersDai HataAssociate at AN Venture PartnersJulie KimRepresentative Director – President and CEO at Takeda VenturesAkiko AmakawaCEO Chief of Staff at Takeda VenturesAsuka MiyabashiraPresident, Japan Pharma Business Unit at Takeda Ventures
+ 71 more